Navigation Links
The IN VIVO Blog Selects First Annual 'Deal of the Year'
Date:1/8/2009

NORWALK, Conn., Jan. 8 /PRNewswire/ -- The readers of The IN VIVO Blog, which provides news, insights and analysis on the biopharmaceutical and medical device industries, have selected a Deal of the Year for 2008 -- Alnylam Pharmaceuticals' RNA interference alliance with Takeda Pharmaceuticals.

More than 2,500 reader votes were cast in this inaugural competition, and Alnylam/Takeda led the polling from start to finish among the 13 nominees selected by The IN VIVO Blog's writers and editorial team at FDC-Windhover, an Elsevier company.

"In a time when investment capital is frozen, winning biotechs are figuring out ways of non-dilutively funding their operations -- not simply by avoiding selling cheap equity but avoiding the sale of product rights as well," said Roger Longman, Managing Director, FDC-Windhover. "Alnylam has managed to monetize its technology base without fundamentally restricting its own product opportunities or diluting its investors -- with its Takeda deal a perfect example of how it pulls off this impressive feat."

"The deal allows Alnylam to end the year with approximately $500 million in cash and sets the RNAi pioneer up for pipeline building down the road. And as for Takeda: it's now the sole big RNAi player in Japan and cements this pharma's place among the most active and creative dealmakers of 2008," Longman said.

For more information, including an explanation of how the nominees were selected for The IN VIVO Blog's Deal of the Year and some commentary from the winner, please visit http://invivoblog.blogspot.com/.

To speak with someone at The IN VIVO Blog about this award, please contact Tom Reller, Elsevier, 212.462.1912 or email T.Reller@Elsevier.com.


'/>"/>
SOURCE FDC-Windhover
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
2. Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software
3. E-Rad Solutions Selects Compressus Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market
4. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
5. GeneSeek Selects the British Midlands as Base for New UK/European Operations
6. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
7. GSA Selects Cascades Technologies, Inc. (CTi) to Support USA.gov
8. ProCure Selects IMPAC as Provider of Oncology Information Systems
9. CIGNA Medical Group Selects Allscripts for Electronic Health Record
10. Holy Cross Hospital Selects Allscripts Electronic Health Record
11. Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Alex,s Lemonade Stand Foundation (ALSF), a leading ... open a state-of-the-art bioinformatics lab, using ,big data, to ... comes as Liz Scott , co-executive director of ... Summit in Washington, D.C. , hosted ... and advocate of pediatric cancer research and awareness. ...
(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life ... development of innovative products and services, announced today that ... denied its petition to review decisions by ... Patent No. 6,258,540 (",540 Patent") are not patent eligible ... Court,s Mayo Collaborative Services v. Prometheus Laboratories decision.  In ...
Breaking Biology Technology:
(Date:6/27/2016)... 27, 2016 Research and Markets has announced ... report to their offering. ... to grow at a CAGR of 12.28% during the ... on an in-depth market analysis with inputs from industry experts. The ... coming years. The report also includes a discussion of the key ...
(Date:6/22/2016)... 2016  The American College of Medical Genetics and Genomics ... as one of the fastest-growing trade shows during the ... Bellagio in Las Vegas . ... growth in each of the following categories: net square feet ... of attendees. The 2015 ACMG Annual Meeting was ranked 23 ...
(Date:6/22/2016)... 2016   Acuant , the leading ... has partnered with RightCrowd ® to ... Management, Self-Service Kiosks and Continuous Workforce Assurance. ... functional enhancements to existing physical access control ... with an automated ID verification and authentication ...
Breaking Biology News(10 mins):